These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Prolongation of cardiac allograft survival by a novel population of autologous CD117+ bone marrow-derived progenitor cells. Grazia TJ; Plenter RJ; Lepper HM; Victorino F; Miyamoto SD; Crossno JT; Pietra BA; Gill RG; Zamora MR Am J Transplant; 2011 Jan; 11(1):34-44. PubMed ID: 21114653 [TBL] [Abstract][Full Text] [Related]
4. CTLA4-Ig plus bone marrow induces long-term allograft survival and donor specific unresponsiveness in the murine model. Evidence for hematopoietic chimerism. Pearson TC; Alexander DZ; Hendrix R; Elwood ET; Linsley PS; Winn KJ; Larsen CP Transplantation; 1996 Apr; 61(7):997-1004. PubMed ID: 8623206 [TBL] [Abstract][Full Text] [Related]
5. Suppression of acute and chronic cardiac allograft rejection in mice by inhibition of chemokine receptor 5 in combination with cyclosporine A. Li J; Xia J; Zhang K; Xu L J Surg Res; 2009 Nov; 157(1):81-90. PubMed ID: 19577762 [TBL] [Abstract][Full Text] [Related]
6. Gr-1intCD11b+ myeloid-derived suppressor cells accumulate in corneal allograft and improve corneal allograft survival. Choi W; Ji YW; Ham HY; Yeo A; Noh H; Jin SE; Song JS; Kim HC; Kim EK; Lee HK J Leukoc Biol; 2016 Dec; 100(6):1453-1463. PubMed ID: 27370015 [TBL] [Abstract][Full Text] [Related]
7. Marked prolongation of cardiac allograft survival by dendritic cells genetically engineered with NF-kappa B oligodeoxyribonucleotide decoys and adenoviral vectors encoding CTLA4-Ig. Bonham CA; Peng L; Liang X; Chen Z; Wang L; Ma L; Hackstein H; Robbins PD; Thomson AW; Fung JJ; Qian S; Lu L J Immunol; 2002 Sep; 169(6):3382-91. PubMed ID: 12218160 [TBL] [Abstract][Full Text] [Related]
8. C5aR1 regulates migration of suppressive myeloid cells required for costimulatory blockade-induced murine allograft survival. Llaudo I; Fribourg M; Medof ME; Conde P; Ochando J; Heeger PS Am J Transplant; 2019 Mar; 19(3):633-645. PubMed ID: 30106232 [TBL] [Abstract][Full Text] [Related]
9. Role of STAT4 and STAT6 signaling in allograft rejection and CTLA4-Ig-mediated tolerance. Zhou P; Szot GL; Guo Z; Kim O; He G; Wang J; Grusby MJ; Newell KA; Thistlethwaite JR; Bluestone JA; Alegre ML J Immunol; 2000 Nov; 165(10):5580-7. PubMed ID: 11067913 [TBL] [Abstract][Full Text] [Related]
10. A combination of anergic cells' adoptive transfer and rapamycin therapy prolongs cardiac allograft survival in mice. Cai Y; Tang XD; Zhou PJ Scand J Immunol; 2005 Mar; 61(3):266-73. PubMed ID: 15787744 [TBL] [Abstract][Full Text] [Related]
11. The calcineurin-NFAT axis controls allograft immunity in myeloid-derived suppressor cells through reprogramming T cell differentiation. Wang X; Bi Y; Xue L; Liao J; Chen X; Lu Y; Zhang Z; Wang J; Liu H; Yang H; Liu G Mol Cell Biol; 2015 Feb; 35(3):598-609. PubMed ID: 25452304 [TBL] [Abstract][Full Text] [Related]
12. Prolongation of cardiac allograft survival by rapamycin and the invariant natural killer T cell glycolipid agonist OCH. Haeryfar SM; Lan Z; Leon-Ponte M; Duffy KR; Ge W; Liu W; Mele T; Garcia B; Wang H Transplantation; 2008 Aug; 86(3):460-8. PubMed ID: 18698251 [TBL] [Abstract][Full Text] [Related]
13. Cytokines regulate the pattern of rejection and susceptibility to cyclosporine therapy in different mouse recipient strains after cardiac allografting. Wang H; Hosiawa KA; Min W; Yang J; Zhang X; Garcia B; Ichim TE; Zhou D; Lian D; Kelvin DJ; Zhong R J Immunol; 2003 Oct; 171(7):3823-36. PubMed ID: 14500684 [TBL] [Abstract][Full Text] [Related]
14. Free bone graft attenuates acute rejection and in combination with cyclosporin a leads to indefinite cardiac allograft survival. Wang H; Ge W; Arp J; Zassoko R; Liu W; Ichim TE; Jiang J; Jevnikar AM; Garcia B J Immunol; 2009 May; 182(10):5970-81. PubMed ID: 19414748 [TBL] [Abstract][Full Text] [Related]
15. Donor antioxidant strategy prolongs cardiac allograft survival by attenuating tissue dendritic cell immunogenicity(†). Jurewicz M; Ueno T; Azzi J; Tanaka K; Murayama T; Yang S; Sayegh MH; Niimi M; Abdi R Am J Transplant; 2011 Feb; 11(2):348-55. PubMed ID: 21182586 [TBL] [Abstract][Full Text] [Related]
16. Prolongation of allograft survival with viral IL-10 transfection in a highly histoincompatible model of rat heart allograft rejection. Zuo Z; Wang C; Carpenter D; Okada Y; Nicolaidou E; Toyoda M; Trento A; Jordan SC Transplantation; 2001 Mar; 71(5):686-91. PubMed ID: 11292303 [TBL] [Abstract][Full Text] [Related]
17. The role of recipient mast cells in acute and chronic cardiac allograft rejection in C57BL/6-KitW-sh/W-sh mice. Itoh S; Nakae S; Velotta JB; Kosuge H; Connolly A; Tsai M; Adachi H; Galli SJ; Robbins RC; Fischbein MP J Heart Lung Transplant; 2010 Apr; 29(4):401-9. PubMed ID: 19818646 [TBL] [Abstract][Full Text] [Related]
18. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. Wu T; Sun C; Chen Z; Zhen Y; Peng J; Qi Z; Yang X; Zhao Y J Immunol; 2012 Nov; 189(10):4989-5000. PubMed ID: 23045614 [TBL] [Abstract][Full Text] [Related]
19. Myeloid-derived Suppressor Cells Recruit CD4(+)/Foxp3(+) Regulatory T Cells in a Murine Cardiac Allograft. Nakamura T; Nakao T; Ashihara E; Yoshimura N Transplant Proc; 2016 May; 48(4):1275-8. PubMed ID: 27320602 [TBL] [Abstract][Full Text] [Related]
20. A novel CD154 monoclonal antibody in acute and chronic rat vascularized cardiac allograft rejection. Yuan X; Dong VM; Coito AJ; Waaga AM; Salama AD; Benjamin CD; Sayegh MH; Chandraker A Transplantation; 2002 Jun; 73(11):1736-42. PubMed ID: 12084995 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]